ROSANO, GIUSEPPE MASSIMO CLAUDIO
 Distribuzione geografica
Continente #
AS - Asia 1.012
NA - Nord America 845
EU - Europa 218
Continente sconosciuto - Info sul continente non disponibili 11
OC - Oceania 3
AF - Africa 2
Totale 2.091
Nazione #
US - Stati Uniti d'America 760
SG - Singapore 406
CN - Cina 310
TR - Turchia 274
IT - Italia 105
CA - Canada 85
UA - Ucraina 37
DE - Germania 21
RU - Federazione Russa 13
EU - Europa 11
GB - Regno Unito 10
IE - Irlanda 10
HK - Hong Kong 9
NL - Olanda 7
FR - Francia 4
IN - India 4
FI - Finlandia 3
ID - Indonesia 3
SE - Svezia 3
AU - Australia 2
MY - Malesia 2
RO - Romania 2
TW - Taiwan 2
CH - Svizzera 1
CZ - Repubblica Ceca 1
EG - Egitto 1
IQ - Iraq 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
TH - Thailandia 1
TN - Tunisia 1
Totale 2.091
Città #
San Mateo 147
Kocaeli 145
Santa Clara 145
Singapore 137
Toronto 82
Houston 53
Shanghai 50
Chandler 44
Wilmington 41
Rome 39
Beijing 34
Guangzhou 28
Lawrence 28
Princeton 28
West Jordan 28
Ashburn 25
Dallas 23
Los Angeles 16
Assago 10
Fairfield 10
Seattle 10
Shenzhen 10
Hong Kong 9
Milan 8
Wandsworth 8
Woodbridge 8
Cambridge 6
Wuhan 6
Boardman 5
Rui'an 5
Wuxi 5
Xi'an 5
Dublin 4
Frankfurt am Main 4
Verona 4
Buffalo 3
Cassino 3
Helsinki 3
Jinhua 3
Medan 3
Nantong 3
Ottawa 3
Andover 2
Aversa 2
Cisterna di Latina 2
Council Bluffs 2
Gatchina 2
Haining 2
Jiaxing 2
Kuala Lumpur 2
Kyiv 2
Labarthe-sur-Lèze 2
Nanjing 2
New Taipei 2
Orsogna 2
Poggibonsi 2
Quanzhou 2
Shaoxing 2
Shijiazhuang 2
St Petersburg 2
Turin 2
Xuzhou 2
Amsterdam 1
Auckland 1
Barlassina 1
Cagliari 1
Casignana 1
Casoria 1
Chesapeake 1
Clearwater 1
Colorno 1
Damietta 1
Dongyang 1
Florence 1
Handan 1
Hangzhou 1
Heishan 1
Heze 1
Kemerovo 1
Lanzhou 1
Launceston 1
Lausanne 1
Linyi 1
London 1
Lucca 1
Luino 1
Melbourne 1
Moscow 1
Napoli 1
Nizhniy Novgorod 1
Nova Milanese 1
Olomouc 1
Phoenix 1
Pingdingshan 1
Pomezia 1
Pune 1
Qingdao 1
Redmond 1
Shakhty 1
Skanes 1
Totale 1.309
Nome #
A Systems Medicine Clinical Platform for Understanding and Managing Non-Communicable Diseases 85
MINERALCORTICOID RECEPTOR ANTAGONISTS FOR THE TREATMENT OF CORTICOID-INDUCED OBESITY 55
Bisphosphonates and adipogenesis: Evidence for alendronate inhibition of adipocyte differentiation in 3T3-L1 preadipocytes through a vitamin D receptor mediated effect 53
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 48
Mineralocorticoid receptor in adipocytes and macrophages: A promising target to fight metabolic syndrome 46
Erratum to: Comparison of Microlife BP A200 Plus and Omron M6 Blood Pressure Monitors to Detect Atrial Fibrillation in Hypertensive Patients 46
Cellular Models for Understanding Adipogenesis, Adipose Dysfunction, and Obesity 44
Endothelial effects of drugs designed to treat erectile dysfunction 43
Potential role of progestogens in the control of adipose tissue and salt sensitivity via interaction with the mineralocorticoid receptor 41
The mineralocorticoid receptor in endothelial physiology and disease: novel concepts in the understanding of erectile dysfunction 40
Essential role of ICAM-1 in aldosterone-induced atherosclerosis 39
Androgens and cardiovascular disease: gender-related differences 37
Vitamin D: a novel player in endothelial function and dysfunction 37
Mineralocorticoid vs glucocorticoid receptors: solo players or team mates in the control of adipogenesis? 37
Mineralocorticoid receptor antagonism induces browning of white adipose tissue through impairment of autophagy and prevents adipocyte dysfunction in high-fat-diet-fed mice 36
On-target antihypertensive treatment in Italy: The ISPIT (Indagine Sicoa Paziente Iperteso a Target) survey study 36
Anticoagulation in "real world" patients with atrial fibrillation in Italy: Results from the ISPAF (Indagine Sicoa Paziente Con Fibrillazione Atriale) survey study 35
Peripheral blood mononuclear cells from mild cognitive impairment patients show deregulation of Bax and Sod1 mRNAs 34
Functional mineralocorticoid receptors in human vascular endothelial cells regulate intercellular adhesion molecule-1 expression and promote leukocyte adhesion 33
Androgens and Adipose Tissue in Males: A Complex and Reciprocal Interplay 33
The role of the mineralocorticoid receptor in adipocyte biology and fat metabolism 32
Exposure to Phosphodiesterase Type 5 Inhibitors Stimulates Aromatase Expression in Human Adipocytes in vitro 32
Phosphodiesterase type 5 (PDE5) in the adipocyte: a novel player in fat metabolism? 31
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 30
Trimetazidine improves exercise performance in patients with peripheral arterial disease 27
A Pooled Analysis of Serum Phosphate Measurements and Potential Hypophosphataemia Events in 45 Interventional Trials with Ferric Carboxymaltose 27
Tai chi enhances the effects of endurance training in the rehabilitation of elderly patients with chronic heart failure. 26
Prevention and Rehabilitation After Heart Transplantation: A Clinical Consensus Statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a Section of ESOT 25
From glucose lowering to treatment of cardiovascular disease: the repositioning of glucose-lowering agents 23
Patient profiling in heart failure for tailoring medical therapy. A consensus document of the Heart Failure Association of the European Society of Cardiology 21
Effects of a short-term exercise training on serum factors involved in ventricular remodelling in chronic heart failure patients 19
Ranolazine 18
Effect of exercise training on serum capacity to induce endothelial cell death in patients with chronic heart failure 17
Exercise training reduces serum capacity to induce endothelial cell death in patients with chronic heart failure 17
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review 17
Metabolic syndrome predicts lower functional recovery in female but not in male patients after an acute cardiac event. 16
Effect of hormone replacement therapy with the anti-mineralocorticoid progestin Drospirenone compared to tibolone on endothelial function and central haemodynamics in post-menopausal women. 14
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 14
Cardiac Metabolism in Myocardial Ischemia 14
ATP secreted by endothelial cells blocks CX₃CL 1-elicited natural killer cell chemotaxis and cytotoxicity via P2Y₁₁ receptor activation 14
Effect of High-Intensity interval training versus moderate continuous training on 24-h blood pressure profile and insulin resistance in patients with chronic heart failure. 14
Dose-response relationship of baroreflex sensitivity and heart rate variability to individually-tailored exercise training in patients with heart failure 14
Usefulness of Nutraceuticals (Armolipid Plus) Versus Ezetimibe and Combination in Statin-Intolerant Patients With Dyslipidemia With Coronary Heart Disease 13
Testosterone therapy in women with chronic heart failure: a pilot double-blind, randomized, placebo-controlled study. 13
Pathophysiological Basis for Nutraceutical Supplementation in Heart Failure: A Comprehensive Review- From the Optimal Nutraceutical Supplementation in Heart Failure (Onus-HF) Working Group. 13
Usefulness of Low-Dose Statin Plus Ezetimibe and/or Nutraceuticals in Patients With Coronary Artery Disease Intolerant to High-Dose Statin Treatment 13
Preventing heart failure: a position paper of the Heart Failure Association in collaboration with the European Association of Preventive Cardiology 13
Mineralocorticoid receptor activation affects skeletal muscle development and metabolism. 13
Chemotherapeutic Drugs and Mitochondrial Dysfunction: Focus on Doxorubicin, Trastuzumab, and Sunitinib 13
Validation of rate of perceived exertion-based exercise training in patients with heart failure: Insights from autonomic nervous system adaptations. 12
Low testosterone levels are associated with coronary artery disease in male patients with angina. 12
Effects of Nebivolol versus Carvedilol in Hypertensive Patients with Chronic Heart Failure 12
Corrigendum to "Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance" [Int. J. Cardiol. 202 (2016) 76-77] 12
The metabolic modulator trimetazidine triggers autophagy and counteracts stress-induced atrophy in skeletal muscle myotubes 12
Metabolic management of diabetic patients with ischaemic heart disease 12
Role of leucocyte count and thyroid-stimulating hormone in evolution of mild cognitive impairment to dementia 11
Effectiveness of nebivolol and hydrochlorothiazide association on blood pressure, glucose, and lipid metabolism in hypertensive patients. 11
Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. 11
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 11
Prevalence, characteristics and prognostic impact of aortic valve disease in patients with heart failure and reduced, mildly reduced, and preserved ejection fraction: An analysis of the ESC Heart Failure Long-Term Registry 11
The mitochondrial metabolic reprogramming agent trimetazidine as an 'exercise mimetic' in cachectic C26-bearing mice 11
COMPARISON BETWEEN INTERVAL TRAINING AND ENDURAND TRAINING ON 24-H BLOOD PRESSURE AND GLUCOSE METABOLISM IN HYPERTENSIVE PATIENTS WITH HEART FAILURE: A PILOT STUDY 11
Response letter to Dr. William's letter to the editor entitled "The CARVIVA HF trial - Is the devil in the detail?" published August 2018 11
Effect of trimetazidine on quality of life in elderly patients with ischemic dilated cardiomyopathy. 11
Pre‐discharge and early post‐discharge management of patients hospitalized for acute heart failure: A scientific statement by the Heart Failure Association of the ESC 11
Cardiac remodelling - Part 1: From cells and tissues to circulating biomarkers. A review from the Study Group on Biomarkers of the Heart Failure Association of the European Society of Cardiology 11
Role of mineralocorticoid receptor and renin-angiotensin-aldosterone system in adipocyte dysfunction and obesity 11
Cytokines are not predictive of Alzheimer's disease in patients with mild cognitive impairment 10
Physical Training Reduces the Ability of Serum from Patients with Heart Failure to Induce Endothelial Cell Death 10
Prevention and rehabilitation after heart transplantation: A clinical consensus statement of the European Association of Preventive Cardiology, Heart Failure Association of the ESC, and the European Cardio Thoracic Transplant Association, a section of ESOT 10
Comparative long term effects of nebivolol and carvedilol in hypertensive heart failure patients 10
Effects of testosterone on the Q-T Interval in older men and older women with chronic heart failure. 10
Effects of chronic testosterone administration on myocardial ischemia, lipid metabolism and insulin resistance in elderly male diabetic patients with coronary artery disease 10
Intensive cardiac rehabilitation improves glucometabolic state of non-diabetic patients with recent coronary artery bypass grafting 10
Addition of ivabradine to betablockers in patients with atrial fibrillation: Effects on heart rate and exercise tolerance 10
Improvement of skeletal muscle performance in ageing by the metabolic modulator Trimetazidine 10
Integration of implantable device therapy in patients with heart failure. A clinical consensus statement from the Heart Failure Association (HFA) and European Heart Rhythm Association (EHRA) of the European Society of Cardiology(ESC>) 10
Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized study 10
Response letter to Dr. William's letter to the editor entitled "The CARVIVA HF trial - Is the devil in the detail?" 10
Ranolazine improves insulin resistance in non-diabetic patients with coronary heart disease. A pilot study. 10
Menopause and cardiovascular disease: the evidence. Rosano GM, Vitale C, Marazzi G, Volterrani M 10
International validation of the Metabolic Exercise test data combined with Cardiac and Kidney Indexes (MECKI) score in heart failure 10
Testosterone and heart failure. 9
Education and certification on heart failure of the Heart Failure Association of the European Society of Cardiology 9
Estrogen acutely increases peripheral blood flow in postmenopausal women. 9
Congestion in heart failure: a circulating biomarker-based perspective. A review from the Biomarkers Working Group of the Heart Failure Association, European Society of Cardiology 9
Comparison of trimetazidine plus sildenafil to chronic nitrates in the control of myocardial ischemia during sexual activity in patients with coronary artery disease. 9
CXCL12 prolongs naive CD4+ T lymphocytes survival via activation of PKA, CREB and Bcl2 and BclXl up-regulation 9
Metabolic therapy for the diabetic patients with ischaemic heart disease. Rosano GM, Vitale C, Volterrani M, Fini M 9
Modulating the metabolism by trimetazidine enhances myoblast differentiation and promotes myogenesis in cachectic tumor-bearing c26 mice 9
Comparison of Low-Dose Statin Versus Low-Dose Statin+Armolipid Plus in High-Intensity Statin-Intolerant Patients With a Previous Coronary Event and Percutaneous Coronary Intervention (ADHERENCE Trial) 9
Clinical practice update on heart failure 2019: pharmacotherapy, procedures, devices and patient management. An expert consensus meeting report of The Heart Failure Association of the European Society of Cardiology 9
Long-term effects of nutraceuticals (berberine, red yeast rice, policosanol) in elderly hypercholesterolemic patients. 9
Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). 9
Left ventricular ejection fraction digit bias and reclassification of heart failure with mildly reduced vs reduced ejection fraction based on the 2021 definition and classification of heart failure 9
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology 9
Mineralocorticoid receptor in adipocytes and macrophages: a promising target to fight metabolic syndrome 9
Heart Rate Control in an Unselected Consecutive Population of Outpatients With Stable Coronary Artery Disease: Analysis of the CARDIf Study Cohort. 8
Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome 8
Matched dose interval and continuous exercise training induce similar cardiorespiratory and metabolic adaptations in patients with heart failure. 8
Totale 1.924
Categoria #
all - tutte 33.210
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 33.210


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202030 0 0 0 0 0 0 0 0 0 0 8 22
2020/2021277 16 17 3 4 7 22 15 8 12 9 148 16
2021/2022288 1 82 83 8 0 0 18 28 5 58 2 3
2022/2023245 61 1 3 14 11 17 0 13 9 93 19 4
2023/2024343 4 0 10 32 9 14 1 22 4 59 14 174
2024/20251.012 93 287 50 30 49 174 57 68 187 17 0 0
Totale 2.246